Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 2570804 | MHC (MHC) | transplantation | NA | NA | NA | unclassified | |
| such rflp analyses will be useful for identifying mhc 'compatible' rabbits for various immunobiological studies, including transplantation. | |||||||
| 2570804 | HLA-DR (HLA-DR) | strain | NA | NA | NA | unclassified | |
| the organization of the rabbit mhc class ii genes has now been studied in greater detail by analysing genomic dna of an inbred iii/j strain and several other rla-d homozygous rabbits, with dna probes derived from cloned r-dr beta genes. | |||||||
| 2573398 | HLA IDENTICAL (HLA-IDENTICAL) | transplantation | NA | NA | NA | only_studied | |
| phenotypic and functional characteristics of peripheral blood mononuclear cells (pbmc) were studied in eight patients with poor graft function following hla-identical t cell-depleted marrow transplantation. | |||||||
| 2629463 | HLA MATCHED (HLA-MATCHED) | transplantation | NA | NA | NA | unclassified | |
| of the 152 patients with saa, 109 were alive between 2 and 132 months following transplantation and the probability of survival at 5 years was 70% (for the patients with grafts from hla-matched siblings) and 100% (for the patients with grafts from monozygous twins). | |||||||
| 2629463 | HLA MATCHED (HLA-MATCHED) | transplantation | NA | NA | NA | unclassified | |
| since 1985, the results of transplantation from hla-matched siblings have improved and the 3-year survival is more than 90% for patients under 20 years old. | |||||||
| 2633201 | HLA-A (HLA-A) | transplantation | NA | NA | NA | positive | |
| other factors which influence allograft survival such as hla-a, -b and -dr matches, number of blood transfusions, immunosuppressive therapy, age, sex, parity, previous positive crossmatch, circulating cytotoxic antibodies matching the graft, prior dialysis, length of time on the waiting list, lapse of time between transfusion and transplantation and the underlying primary diagnosis were also considered using the gehan generalized wilcoxon test or the chi 2 approximation. | |||||||
| 2633201 | HLA-DR (HLA-DR) | transplantation | NA | NA | NA | positive | |
| other factors which influence allograft survival such as hla-a, -b and -dr matches, number of blood transfusions, immunosuppressive therapy, age, sex, parity, previous positive crossmatch, circulating cytotoxic antibodies matching the graft, prior dialysis, length of time on the waiting list, lapse of time between transfusion and transplantation and the underlying primary diagnosis were also considered using the gehan generalized wilcoxon test or the chi 2 approximation. | |||||||
| 2645417 | HLA IDENTICAL (HLA-IDENTICAL) | azathioprine | NA | prednisone | NA | unclassified | |
| NA | |||||||
| 2645417 | HLA IDENTICAL (HLA-IDENTICAL) | azathioprine | NA | prednisone | NA | positive | |
| NA | |||||||
| 2646783 | HLA-A (HLA-A) | transplantation | NA | NA | NA | unclassified | |
| human liver allografts deliver soluble class i (hla-a and -b) transplantation antigens into the recipients' circulation. | |||||||
Copyright 2024